Related Experiment Video
Updated: Nov 10, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential
Neha Vithani1, Michael D Ward1, Maxwell I Zimmerman1
1Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri; Center for Science and Engineering of Living Systems, Washington University in St. Louis, St. Louis, Missouri.
Abstract:
Coronaviruses have caused multiple epidemics in the past two decades, in addition to the current COVID-19 pandemic that is severely damaging global health and the economy. Coronaviruses employ between 20 and 30 proteins to carry out their viral replication cycle, including infection, immune evasion, and replication. Among these, nonstructural protein 16 (Nsp16), a 2'-O-methyltransferase, plays an essential role in immune evasion. Nsp16 achieves this by mimicking its human homolog, CMTr1, which methylates mRNA to enhance translation efficiency and distinguish self from other. Unlike human CMTr1, Nsp16 requires a binding partner, Nsp10, to activate its enzymatic activity. The requirement of this binding partner presents two questions that we investigate in this manuscript. First, how does Nsp10 activate Nsp16? Although experimentally derived structures of the active Nsp16/Nsp10 complex exist, structures of inactive, monomeric Nsp16 have yet to be solved. Therefore, it is unclear how Nsp10 activates Nsp16. Using over 1 ms of molecular dynamics simulations of both Nsp16 and its complex with Nsp10, we investigate how the presence of Nsp10 shifts Nsp16's conformational ensemble to activate it. Second, guided by this activation mechanism and Markov state models, we investigate whether Nsp16 adopts inactive structures with cryptic pockets that, if targeted with a small molecule, could inhibit Nsp16 by stabilizing its inactive state. After identifying such a pocket in SARS-CoV2 Nsp16, we show that this cryptic pocket also opens in SARS-CoV1 and MERS but not in human CMTr1. Therefore, it may be possible to develop pan-coronavirus antivirals that target this cryptic pocket.
Insights
Coronaviruses use nonstructural protein 16 (Nsp16) for immune evasion. This study reveals how Nsp10 activates Nsp16 and identifies a potential target for pan-coronavirus antivirals.
Area of Science:
- Virology
- Structural Biology
- Drug Discovery
Background:
- Coronaviruses, including SARS-CoV-2, pose significant global health threats due to their rapid replication and immune evasion strategies.
- Nonstructural protein 16 (Nsp16), a 2'-O-methyltransferase, is crucial for coronavirus immune evasion by methylating viral RNA.
- Nsp16 requires its binding partner, Nsp10, for enzymatic activation, a mechanism not fully understood.
Purpose of the Study:
- To elucidate the activation mechanism of Nsp16 by its binding partner Nsp10.
- To identify potential druggable cryptic pockets in Nsp16 for antiviral development.
- To explore the possibility of developing pan-coronavirus antivirals targeting Nsp16.
Main Methods:
- Extensive molecular dynamics (MD) simulations (over 1 ms) of Nsp16 and the Nsp16/Nsp10 complex.
- Application of Markov state models to analyze conformational changes and identify functional states.
- Structural analysis to detect and characterize cryptic pockets within Nsp16.
Main Results:
- Nsp10 binding induces significant conformational shifts in Nsp16, activating its methyltransferase activity.
- A conserved cryptic pocket was identified in SARS-CoV-2 Nsp16, which is also present in SARS-CoV-1 and MERS Nsp16.
- This cryptic pocket is absent in the human homolog, CMTr1, suggesting Nsp16-specific targeting.
Conclusions:
- The study provides a detailed mechanism for Nsp10-mediated activation of Nsp16.
- The identified cryptic pocket represents a promising target for developing novel, broad-spectrum antiviral therapies against coronaviruses.
- Targeting this pocket could stabilize Nsp16 in its inactive state, inhibiting viral replication.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
The Antiviral System of Bacteria and Archaea: CRISPR
Leaky Scanning
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...

